Kinnov Therapeutics was present at the 37th ECNP congress https://www.ecnp.eu/congress2024/ECNPcongress, in Milan 21-24 Sep, 2024.

Within the scope of ECNP’s New Medications Symposium, Prof Henri-Jean Aubin and Julien Guiraud were invited to present results of phase 2 clinical trials.

The annual ECNP Congress is Europe’s premier scientific meeting for disease-oriented brain research.

Prof Henri-Jean Aubin was Principal Investigator for phase 2 clinical trial.

Julien Guiraud (Vergio Consulting) is co-author of phase 2 clinical trial publication.